Health care stocks were higher in Monday's premarket hours, with the Health Care Select Sector SPDR Fund (XLV) and the iShares Biotechnology ETF (IBB) each advancing by 0.3% recently.
Regional Health Properties (RHE) and SunLink Health Systems (SSY) said they have agreed to merge in an all-stock deal. Regional Health shares soared more than 214% and SunLink Health shares were over 24% higher in recent premarket activity.
SciSparc (SPRC) announced the publication of a European patent application that its collaboration partner Clearmind Medicine (CMND) submitted with the European Patent Office for a binge behavior psychedelic combination treatment. Shares of SciSparc surged past 68% and Clearmind Medicine shares rose by over 6% pre-bell.
CytoMed Therapeutics (GDTC) shares were up over 20% after the company said it has signed a five-year business and research collaboration deal with SunAct Cancer Institute to explore the efficacy, potency, safety, and tolerability of CytoMed's proprietary allogeneic gamma delta T cells to treat different cancers.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。